Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

BACKGROUND: Waning of vaccine protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The persistence of BNT162b2 (Pfizer–BioNTech) vaccine effectiveness against infection and disease in Qatar, where the B.1.351 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chemaitelly, Hiam, Tang, Patrick, Hasan, Mohammad R., AlMukdad, Sawsan, Yassine, Hadi M., Benslimane, Fatiha M., Al Khatib, Hebah A., Coyle, Peter, Ayoub, Houssein H., Al Kanaani, Zaina, Al Kuwari, Einas, Jeremijenko, Andrew, Kaleeckal, Anvar H., Latif, Ali N., Shaik, Riyazuddin M., Abdul Rahim, Hanan F., Nasrallah, Gheyath K., Al Kuwari, Mohamed G., Al Romaihi, Hamad E., Butt, Adeel A., Al-Thani, Mohamed H., Al Khal, Abdullatif, Bertollini, Roberto, Abu-Raddad, Laith J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522799/
https://www.ncbi.nlm.nih.gov/pubmed/34614327
http://dx.doi.org/10.1056/NEJMoa2114114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522799/
https://www.ncbi.nlm.nih.gov/pubmed/34614327
http://dx.doi.org/10.1056/NEJMoa2114114

Ejemplares similares